I’m pleased to share that the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) at Memorial Sloan Kettering Cancer Center (MSK) is now accepting applications for our PhD programs in Cancer Engineering and Cancer Biology.
The Pat and Ian Cook Cancer Engineering Graduate Program provides training that merges cancer biology with bioengineering. Established in 2023 to run alongside GSK’s Cancer Biology PhD Program, this program teaches scientists and engineers how to solve biological and clinical problems in cancer science and medicine through technological innovation and engineering. The Cancer Biology PhD program, which is recruiting its 20th class, provides research training in biomedical sciences, including topics ranging from biochemistry and genetics to human physiology and pathophysiology.
Students in both programs will join one of more than 130 laboratories at MSK where they will examine cancer science through the lenses of basic and translational research.
At GSK, we are committed to training a new generation of scientists and engineers who will advance the frontiers of biomedical knowledge. Established in 2006, our graduate school provides an interactive environment in which PhD students get the full benefit of the close integration of basic science and translational research for which MSK is known. Our programs offer students a wide range of learning and research opportunities with our internationally renowned faculty in a highly innovative and collegial scientific environment.
I hope you will visit our website to learn more about us and share information about our programs with your students who are considering careers in the biomedical sciences.
If you have questions about our Cancer Biology or Cancer Engineering Programs, don’t hesitate to contact us at gradstudies@sloankettering.edu
No comments:
Post a Comment